Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201011829 Principal Investigator: Van Tine, Brian
Title: Phase 1b Open-Label Study of the Safety and Clinical Activity of Crizotinib (PF-02341066) in Tumors with Genetic Events Involving the Anaplastic Lymphoma Kinase (ALK) Gene Locus
Phase: I Disease Site: Soft Tissue
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to see whether a new investigational drug, crizotinib, can prevent or slow down cancer from growing, and to assess any side effects that patients may have.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)